Online pharma research on the rise: study

Share this article:
Three out of five pharmaceutical market research studies—60 % of those fielded in the US and abroad—were conducted online last year, a new study shows.

The results of the 2007 Medefield Pharmaceutical Market Research Trends Study shows that Internet-based market research is conducted three times more often than telephone
interviews and nearly four times as often as those performed face-to-face.

According to the study there has been solid growth in the online category. Last year's increase -- up 43 percent -- shows a sharper curve than in previous years, Medefield said.

Meanwhile, the use of face-to-face and telephone research experienced a decline, with face-to-face falling 28% and telephone interviews dropping 41% since 2006, the study showed.

Johanne Guarda SVP of Medefield America said market researchers have grown more
ambitious in recent years as they design “more complex studies with higher goals, aimed at reaching more physicians geographically, within a cross-section of specialties.”

More than 20 global pharmaceutical and biotech companies were represented in the study including AstraZeneca, Pfizer, Wyeth, Novartis, Roche and Bristol-Myers Squibb.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...